Alaa M. Abdelrahman
Al Minya, MN 61519, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Machine learning-assisted identification and validation of NRP1 inhibitors through molecular docking and dynamics simulations.
Journal: Scientific reports
Published: May 06, 2026
Insights into SIRT2 inhibition from machine learning-assisted multi-level screening of the NCI database.
Journal: Scientific reports
Published: March 18, 2026
Insights from integrated covalent docking and molecular dynamics simulations of nirmatrelvir analogs as potential SARS-CoV-2 Mpro inhibitors.
Journal: Scientific reports
Published: July 16, 2025
Drug Repurposing Investigation for Combating Ebola Virus Disease: Database Mining, Docking Calculations, Molecular Dynamics, and Density Functional Theory Study.
Journal: ChemistryOpen
Published: June 12, 2025
In Silico Mining of the Streptome Database for Hunting Putative Candidates to Allosterically Inhibit the Dengue Virus (Serotype 2) RdRp.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 11, 2025
Structural and Energetic Insights into the Binding of L- and D-Arginine Analogs with Neuropilin-1 (NRP1): Molecular Docking, Molecular Dynamics and DFT Calculations.
Journal: Cell biochemistry and biophysics
Published: April 04, 2025
In Silico Mining of NPACT Database Toward Identification of EBNA1 Inhibitor: Virtual Screening, Molecular Dynamics Simulations, and DFT Calculations.
Journal: Journal of tropical medicine
Published: January 10, 2025
Hunting potential SIRT2 inhibitors towards cancer treatment: Drug repurposing, molecular dynamics, and binding energy computations.
Journal: Biochemical and biophysical research communications
Published: January 05, 2025
Exploring marine natural products for identifying putative candidates as EBNA1 inhibitors: An insight from molecular docking, molecular dynamics, and DFT computations.
Journal: Biochemical and biophysical research communications
Published: August 14, 2024
Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulations.
Journal: PloS one
Published: July 04, 2024
Last Updated: 09/26/2026